[{"address1": "177 East Colorado Boulevard", "address2": "Suite 700", "city": "Pasadena", "state": "CA", "zip": "91105", "country": "United States", "phone": "626 304 3400", "fax": "626 304 3401", "website": "https://arrowheadpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.", "fullTimeEmployees": 711, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher R. Anzalone Ph.D.", "age": 56, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2104473, "exercisedValue": 1024000, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  O'Brien J.D., PharmD", "age": 61, "title": "COO, General Counsel & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 998520, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James C. Hamilton M.D., MBA", "age": 47, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 897694, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark M. Davis Ph.D.", "title": "Founder and Founder & Director of Insert Therapeutics Inc & Calando", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel J. Apel", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vincent  Anzalone CFA", "title": "Head of Investor Relations & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard  Lovy", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bruce D. Given M.D.", "age": 71, "title": "Chief Medical Scientist", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 486308, "exercisedValue": 5934362, "unexercisedValue": 6159876}, {"maxAge": 1, "name": "Dr. Mark  Seefeld", "age": 71, "title": "Head of Toxicology & VP", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Aaron  Tan", "title": "Head of Tax", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 3, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.arrowheadresearch.com/invest.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 65.0, "open": 65.5, "dayLow": 63.4501, "dayHigh": 67.0, "regularMarketPreviousClose": 65.0, "regularMarketOpen": 65.5, "regularMarketDayLow": 63.4501, "regularMarketDayHigh": 67.0, "payoutRatio": 0.0, "beta": 1.218, "forwardPE": -14.228099, "volume": 2351035, "regularMarketVolume": 2351035, "averageVolume": 2590547, "averageVolume10days": 3092400, "averageDailyVolume10Day": 3092400, "bid": 47.89, "ask": 80.75, "bidSize": 2, "askSize": 2, "marketCap": 8970773504, "fiftyTwoWeekLow": 9.57, "fiftyTwoWeekHigh": 76.76, "allTimeHigh": 2925.0, "allTimeLow": 1.2, "priceToSalesTrailing12Months": 10.815353, "fiftyDayAverage": 55.3311, "twoHundredDayAverage": 29.176775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8631744512, "profitMargins": -0.0019699999, "floatShares": 116971414, "sharesOutstanding": 138952516, "sharesShort": 10234550, "sharesShortPriorMonth": 11596104, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0754, "heldPercentInsiders": 0.04385, "heldPercentInstitutions": 0.84762, "shortRatio": 2.93, "shortPercentOfFloat": 0.097799994, "impliedSharesOutstanding": 138952517, "bookValue": 3.434, "priceToBook": 18.800232, "lastFiscalYearEnd": 1759190400, "nextFiscalYearEnd": 1790726400, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -1631000, "trailingEps": -0.01, "forwardEps": -4.5375, "lastSplitFactor": "1:10", "lastSplitDate": 1321488000, "enterpriseToRevenue": 10.407, "enterpriseToEbitda": 70.593, "52WeekChange": 2.4373348, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 64.56, "targetHighPrice": 100.0, "targetLowPrice": 35.0, "targetMeanPrice": 77.90909, "targetMedianPrice": 81.0, "recommendationMean": 1.76923, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 917465984, "totalCashPerShare": 6.756, "ebitda": 122274000, "totalDebt": 743980992, "quickRatio": 4.728, "currentRatio": 4.863, "totalRevenue": 829448000, "debtToEquity": 147.787, "revenuePerShare": 6.201, "returnOnAssets": 0.04868, "returnOnEquity": 0.08672, "grossProfits": 829448000, "freeCashflow": 96153624, "operatingCashflow": 179552000, "grossMargins": 1.0, "ebitdaMargins": 0.14741999, "operatingMargins": 0.17197001, "financialCurrency": "USD", "symbol": "ARWR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.676927, "regularMarketPrice": 64.56, "shortName": "Arrowhead Pharmaceuticals, Inc.", "longName": "Arrowhead Pharmaceuticals, Inc.", "marketState": "CLOSED", "earningsTimestamp": 1764104400, "earningsTimestampStart": 1770670800, "earningsTimestampEnd": 1770670800, "earningsCallTimestampStart": 1764106200, "earningsCallTimestampEnd": 1764106200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.01, "epsForward": -4.5375, "epsCurrentYear": -3.459, "priceEpsCurrentYear": -18.664352, "fiftyDayAverageChange": 9.228897, "fiftyDayAverageChangePercent": 0.16679403, "twoHundredDayAverageChange": 35.383224, "twoHundredDayAverageChangePercent": 1.2127188, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1768006075, "regularMarketTime": 1767992401, "exchange": "NMS", "messageBoardId": "finmb_203142", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 756052200000, "postMarketChangePercent": 0.68154037, "postMarketPrice": 65.0, "postMarketChange": 0.44000244, "regularMarketChange": -0.440002, "regularMarketDayRange": "63.4501 - 67.0", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2590547, "fiftyTwoWeekLowChange": 54.989998, "fiftyTwoWeekLowChangePercent": 5.7460814, "fiftyTwoWeekRange": "9.57 - 76.76", "fiftyTwoWeekHighChange": -12.200005, "fiftyTwoWeekHighChangePercent": -0.158937, "fiftyTwoWeekChangePercent": 243.73347, "displayName": "Arrowhead Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]